These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22152244)

  • 21. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
    Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
    Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
    Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
    Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.
    Maina V; Sutti S; Locatelli I; Vidali M; Mombello C; Bozzola C; Albano E
    Clin Sci (Lond); 2012 Jun; 122(11):545-53. PubMed ID: 22142284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of inflammatory stress on hepatic cholesterol accumulation and hepatic fibrosis in C57BL/6J mice].
    Liu Y; Zuo GQ; Zhao L; Chen YX; Ruan XZ; Zuo DY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):116-20. PubMed ID: 23663883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis.
    Wang HY; Cheng ML
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):179-84. PubMed ID: 18397855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
    Ip E; Farrell G; Hall P; Robertson G; Leclercq I
    Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
    Yu J; Chu ES; Hui AY; Cheung KF; Chan HL; Leung WK; Farrell GC; Sung JJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):53-9. PubMed ID: 17350593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
    Inoue M; Ohtake T; Motomura W; Takahashi N; Hosoki Y; Miyoshi S; Suzuki Y; Saito H; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2005 Oct; 336(1):215-22. PubMed ID: 16125673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.
    Wang RQ; Nan YM; Wu WJ; Kong LB; Han F; Zhao SX; Kong L; Yu J
    Lipids Health Dis; 2011 Feb; 10():31. PubMed ID: 21314960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.